Bayer AG · XETR:BAYN

Bayer — Fact Sheet (October 2025)

1 slide from Bayer's fact sheet, Oct 30, 2025

1. Slide 1: Pharmaceuticals – Pipeline Overview (Stand: 30. Oktober 2025)

   Pharmaceuticals – Pipeline Overview1 (Stand: 30. Oktober 2025) Phase I Phase II Phase III VVD KEAP1 Akt (VVD-130037 aka Sevabertinib (HER2/mEGFR Inhibitor) (BAY 2927088) Darolutamide (AR-Inhibitor) NRF2 Inh, BAY 3605349) Metastasierte oder inoperable solide Tumore mit HER2-aktivierenden Adjuvant Pro

Bayer — Fact Sheet (October 2025) on 6ix